Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Want to cut your energy bills? Here’s how five experts are doing it 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William Blair 37th Annual Growth Stock Conference on June 13, 2017 at 2:10 p.m. Central Time in Chicago.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's proprietary Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 [email protected]
